notice of allowance
-
Biologics
BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
Notice of Allowance Grants Protection for BioRestorative’s Phase 2 Clinical Program to Treat Chronic Lumbar Disc Disease MELVILLE, N.Y., Feb.…
Read More » -
Spine
Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant for Motion Preservation or Fusion
– New Patent will Strengthen Company’s IP Portfolio CARLSBAD, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora…
Read More » -
Regulatory
Captiva Spine Granted New Patent in the U.S. for Unique Approach to Site Preparation for Posterior SI Joint Fusion Surgery
October 1, 2020 / by Captiva Spine TRANSFASTEN® POSTERIOR SI FUSION SYSTEM Captiva Spine, Inc., developer and distributor of intuitive spine fusion devices, announced today they received a “Notice of Allowance” by…
Read More » -
Regulatory
Aurora Spine Receives “Notice of Allowance” for Patent: DEXA Technology™ The World’s First Patient-Matched Interbody Implant Technology to Enable Improved Spine Surgery
CARLSBAD, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) today announced…
Read More » -
Neuro
InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells
CAMBRIDGE, Mass. (June 22, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that it has received a Notice of Allowance…
Read More »